Market research on the consumer health industry. Our reports feat...
Market research on the consumer health industry. Our reports feature a wealth of standardised and cross-comparable statistics including total market sizes, market share and share data, distribution and industry trends.
In 2024, cough, cold, and allergy (hay fever) remedies is expected to see a slowdown in retail current value growth in Vietnam, as the category becomes more mature. Although still seeing solid growth, consumer demand for such products has become more…
During 2024’s spring and summer months, the UK experienced another strong hay fever period as climate change prolonged the season, while increasing the potency of some pollen varieties. This supported greater consumer reliance on antihistamines and…
Value sales of cough, cold and allergy (hay fever) remedies in the United Arab Emirates continue to rise. In April 2024, the United Arab Emirates experienced an unprecedented flood (in an area that rarely sees rain), which had widespread effects…
The market for cough, cold, and allergy (hay fever) remedies in the Philippines is projected to experience robust growth in current value terms in 2024. This trend is being driven by rising urbanisation, which creates favourable conditions for the…
Sales of cough, cold and allergy (hay fever) remedies in Thailand continue to rise strongly in 2024, due to a number of factors. As a result of industrialisation, urbanisation and greater traffic levels on the roads, there are rising levels of…
Cough, cold and allergy remedies in New Zealand is set to see slow retail current value growth in 2024. During the period 2020-2021, there were movement restrictions and reduced levels of social interaction due to the government response to the…
Cough, cold and allergy (hay fever) remedies is set to maintain double-digit retail current value growth in Mexico in 2024. In Mexico there has been a change in attitude regarding taking antibiotics, because there is greater awareness of the overuse…
In 2024, cough, cold, and allergy (hay fever) remedies in Japan is set to see only slow growth in retail current value terms. Despite the category benefiting from the proliferation of various infectious diseases in this year, including COVID-19,…
Cough, cold and allergy (hay fever) remedies is set to see retail value sales fall in current terms in Italy in 2024. Remedies for coughs and colds suffered from the waning of the flu season in early 2024 compared to the previous season, although the…
Sales of cough, cold and allergy (hay fever) remedies in Hong Kong continue to rise, as the city grapples with recurring influenza seasons, exacerbated by the spike in inbound and outbound travellers. However, this dynamic environment has been…
Sales of cough and cold remedies have gradually been normalising in China in 2024, although from a high base established in 2023 during the wave of COVID-19 infections. Persistent respiratory illnesses throughout late 2023 and early 2024 have…
Despite registering healthy growth during 2023, cough, cold, and allergy (hay fever) remedies in Chile fell well below industry expectations. This was primarily due to the climate effect, a determining factor in demand for remedies that address…
Overall, cough, cold and allergy (hay fever) remedies in Belgium is quite stable in retail current value terms, with a slight increase projected over 2024. This performance is supported by price rises as many categories are predicted to see dips in…
Cough, cold and allergy (hay fever) remedies in Argentina face a sizeable decline in constant value sales over 2024. Average income levels remain below historical standards with many Argentinean households facing reduced purchasing power in the face…
Cough, cold and allergy remedies is set to see a single-digit retail current value decline in the US in 2024, which is a continuation of normalisation after the extreme double-digit growth brought about by the “tripledemic” in 2022. While most…
Sales for cough, cold and allergy (hay fever) remedies in France is rising in current value terms in 2024, primarily driven by price hikes. While positive, growth is modest compared to the highs of 2022 which followed a year of increased incidences…
Cough, cold and allergy (hay fever) remedies is growing at a moderate pace in current value terms in 2024. Sales rose sharply during the pandemic as some consumers turned to these products to treat mild symptoms of COVID-19. With the pandemic coming…
The habit of self-medication continues to fuel healthy growth in cough, cold, and allergy (hay fever) remedies in Algeria in 2024. As a result, the outlook for the category remains positive, with most product segments experiencing consistent…
In 2023, cough, cold and allergy (hay fever) remedies is set to maintain dynamic current value growth in Brazil. In this year, the conclusion of the Public Health Emergency of International Concern (PHEIC) for COVID-19, as declared by the World…
Locally preferred alternatives, like consuming honey, ginger, and lemon infusions, enjoy widespread popularity among the locals. In households with lower incomes, natural remedies often take precedence as the initial choice before resorting to…